e.g., HRA000087; HRA000150
  1. Home
  2. Browse
  3. HRA003962
HRA003962
Title:
KK-LC-1 represents a feasible therapeutic target to eliminate ALDH+ stem cells in triple negative breast cancer
Release date:
2023-03-31
Description:
High expression of KK-LC-1 is associated with poor prognosis in triple-negative breast cancer patients. It is necessary to explore the mechanisms by which KK-LC-1 regulates the malignant behavior of triple-negative breast cancer, and to clarify which genes and pathways KK-LC-1 regulates in triple-negative breast cancer cells.
Data Accessibility:   
Open access
BioProject:
PRJCA012087
Study type:
Cell line related study
Dataset Download
MetaData:
HRA003962.xlsx
Files:
HTTPS：https://download.cncb.ac.cn/gsa-human/HRA003962
Aspera Command Line:  Help   
FTP：ftp://download.big.ac.cn/gsa-human/HRA003962

 Note: HTTP download speed may be slow. It is highly recommended that you download the dataset using a dedicated FTP tool (such as FileZilla Client) or Asepra Command Line.

Individuals & samples
Individual Accession
Individual Name
Gender
Sample Accession
Sample Name
Sample Description
Individual Accession
Individual Name
Gender
Sample Accession
Sample Name
Sample Description
HRI368770MDA-MB-231/WT1femaleHRS554962WT1wild type
HRI368771MDA-MB-231/WT2femaleHRS554963WT2wild type
HRI368772MDA-MB-231/WT3femaleHRS554964WT3wild type
HRI368773MDA-MB-231/KO1femaleHRS554965KO1Knockout of KK-LC-1
HRI368774MDA-MB-231/KO2femaleHRS554966KO2Knockout of KK-LC-1
HRI368775MDA-MB-231/KO3femaleHRS554967KO3Knockout of KK-LC-1
Showing 1 to 6 of 6 rows rows per page
Files
Download
Run accession
Files
Experiment
Experiment title
Platform
Sample
Run accession
Files
Experiment
Experiment title
Platform
Sample
HRR913096HRR913096_f1.fastq.gz (1.45 GB)HRX664473control group 1Illumina HiSeq 3000HRS554962 (SAMC2551250)
HRR913096HRR913096_r2.fastq.gz (1.53 GB)HRX664473control group 1Illumina HiSeq 3000HRS554962 (SAMC2551250)
HRR913097HRR913097_f1.fastq.gz (1.43 GB)HRX664474control group 2Illumina HiSeq 3000HRS554963 (SAMC2551254)
HRR913097HRR913097_r2.fastq.gz (1.48 GB)HRX664474control group 2Illumina HiSeq 3000HRS554963 (SAMC2551254)
HRR913098HRR913098_f1.fastq.gz (1.56 GB)HRX664475control group 3Illumina HiSeq 3000HRS554964 (SAMC2551257)
HRR913098HRR913098_r2.fastq.gz (1.61 GB)HRX664475control group 3Illumina HiSeq 3000HRS554964 (SAMC2551257)
HRR913099HRR913099_f1.fastq.gz (1.56 GB)HRX664476knockout group 1Illumina HiSeq 3000HRS554965 (SAMC2551261)
HRR913099HRR913099_r2.fastq.gz (1.60 GB)HRX664476knockout group 1Illumina HiSeq 3000HRS554965 (SAMC2551261)
HRR913100HRR913100_f1.fastq.gz (1.42 GB)HRX664477knockout group 2Illumina HiSeq 3000HRS554966 (SAMC2551264)
HRR913100HRR913100_r2.fastq.gz (1.53 GB)HRX664477knockout group 2Illumina HiSeq 3000HRS554966 (SAMC2551264)
Showing 1 to 10 of 12 rows rows per page
Submitter:   Liu Caigang / liucg@sj-hospital.org
Organization:   Shengjing Hospital of China Medical University
Submission date:   2023-02-11